| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,749 |
5,039 |
$268K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,706 |
4,752 |
$212K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,499 |
5,202 |
$185K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,637 |
2,196 |
$149K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,025 |
1,651 |
$142K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,732 |
1,298 |
$52K |
| 81025 |
|
3,567 |
2,839 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,765 |
928 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,081 |
878 |
$12K |
| 87905 |
|
1,314 |
1,147 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
241 |
209 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
171 |
144 |
$5K |
| 99459 |
|
166 |
160 |
$2K |
| 0031A |
|
16 |
16 |
$1K |
| 81003 |
|
847 |
729 |
$1K |
| 87428 |
|
26 |
26 |
$807.86 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
49 |
40 |
$425.77 |
| 87808 |
|
39 |
29 |
$389.98 |
| 87807 |
|
28 |
23 |
$235.90 |
| 87110 |
|
19 |
17 |
$132.30 |
| 81002 |
|
59 |
45 |
$120.06 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
21 |
14 |
$12.24 |